A key part of J-Clinic, the MIT-Takeda Program will create educational opportunities and support cutting-edge research to positively impact human health.
Lori LoTurco | School of Engineering
January 6, 2020
MIT’s School of Engineering and Takeda Pharmaceuticals Company Limited today announced the MIT-Takeda Program to fuel the development and application of artificial intelligence (AI) capabilities to benefit human health and drug development. Centered within the Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic), the new program will leverage the combined expertise of both organizations, and is supported by Takeda’s three-year investment (with the potential for a two-year extension).